Our founder, Dr. Nikola Cihoric, is featured in Forbes, where he shares how years in oncology and research exposed a systemic issue: trials delayed not by science, but by slow, fragmented systems.

Driven by that frustration, he set out to build something better.

That’s how oomnia was born, a unified clinical research platform designed to simplify setup, connect data, and give teams the clarity they need to move faster and smarter.

With oomnia we are not just fixing trial inefficiencies; we are creating a new standard.

Read the full article